Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

313
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
313

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A systematic review and meta-analysis of metalloproteinases in patients with Alzheimer's disease and mild cognitive impairment.

Journal of Alzheimer's disease : JAD·2026
Same author

Advancing EEG-based assessment of consciousness and cognition in prolonged disorders of consciousness.

Communications medicine·2026
Same author

Limitations of Variational Laplace-Based Dynamic Causal Modelling for Multistable Cortical Circuits.

Neuroinformatics·2026
Same author

Multimorbidity trajectories and their sex-specific impacts on risk of mortality and re-hospitalisation.

Scientific reports·2026
Same author

Therapeutic efficacy of synthetic analogues of gut hormones in a mouse model of Alzheimer's disease.

Neuroscience·2026
Same author

The role of obesity and Type 2 diabetes in lung health: A systematic review (2024).

PloS one·2026

Related Experiment Video

Updated: May 8, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

897

Autoencoder imputation of missing heterogeneous data for Alzheimer's disease classification.

Namitha Thalekkara Haridas1, Jose M Sanchez-Bornot1, Paula L McClean2

  • 1Intelligent Systems Research Centre, School of Computing, Engineering and Intelligent Systems Ulster University, Magee campus Derry∼Londonderry Northern Ireland UK.

Healthcare Technology Letters
|December 25, 2024
PubMed
Summary
This summary is machine-generated.

This study shows denoising autoencoders effectively impute missing Alzheimer's disease data, improving diagnostic accuracy. Machine learning models using imputed data achieve robust prediction, even with significant data loss.

Keywords:
data miningdata reductiondecision support systemsfeature extractionfeature selectionlearning (artificial intelligence)medical diagnostic computingneural nets

More Related Videos

Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease
04:22

Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease

Published on: May 20, 2024

723
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.4K

Related Experiment Videos

Last Updated: May 8, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

897
Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease
04:22

Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease

Published on: May 20, 2024

723
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.4K

Area of Science:

  • Artificial Intelligence in Medicine
  • Neuroscience Data Analysis
  • Biomedical Informatics

Background:

  • Missing data is a major obstacle in Alzheimer's disease (AD) diagnosis and research.
  • Existing data imputation methods for AD data have limitations, especially with deep learning.
  • Heterogeneous AD datasets (tau-PET, MRI, genetics, clinical assessments) present unique imputation challenges.

Purpose of the Study:

  • To evaluate denoising autoencoder (DAE) effectiveness for imputing missing key features in comprehensive AD datasets.
  • To assess DAE performance in handling extreme missingness (≥40%) in AD-related features.
  • To integrate DAE-extracted latent features with traditional features for improved AD classification.

Main Methods:

  • Utilized a denoising autoencoder for imputing missing data in heterogeneous AD datasets.
  • Focused on key AD progression-dependent features like maternal history of AD, APOE ε4 alleles, and Clinical Dementia Rating.
  • Employed random forest classification with 10-fold cross-validation on imputed and feature-selected datasets.

Main Results:

  • Imputed datasets demonstrated robust Alzheimer's disease predictive performance (accuracy: 79%-85%; precision: 71%-85%) across various missingness levels.
  • High recall values were achieved even with 40% missing data.
  • Feature-selected datasets, including autoencoder-derived features, outperformed the original complete dataset in classification scores.

Conclusions:

  • Denoising autoencoders are effective and robust for imputing crucial missing information in Alzheimer's disease data.
  • This imputation strategy enhances the reliability of AI-based clinical decision support systems for AD prediction.
  • The study highlights the potential of deep learning for handling complex, incomplete biomedical data.